ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Candidiasis Therapeutics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-15R13882
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Candidiasis Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Candidiasis Therapeutics Market Research Report 2025

Code: QYRE-Auto-15R13882
Report
September 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
F Hoffmann La Roche Ltd
Bayer-Algeta
Merrion Pharmaceuticals Plc.
Genta Incorporated
Galapagos
Digna Biotech, S.L.
Amura Holdings
Amgen Inc
Ablynx NV
Catena Pharmaceuticals Inc.

Candidiasis Therapeutics Market Size

The global market for Candidiasis Therapeutics was valued at US$ 3202 million in the year 2024 and is projected to reach a revised size of US$ 3979 million by 2031, growing at a CAGR of 3.2% during the forecast period.

Candidiasis Therapeutics Market

Candidiasis Therapeutics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Candidiasis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Candidiasis Therapeutics.
The Candidiasis Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Candidiasis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Candidiasis Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Candidiasis Therapeutics Market Report

Report Metric Details
Report Name Candidiasis Therapeutics Market
Accounted market size in year US$ 3202 million
Forecasted market size in 2031 US$ 3979 million
CAGR 3.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Multispecialty Hospitals
  • Cancer Research Institutes
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis AG, Amgen, F. Hoffmann-La Roche Ltd., Bayer-Algeta, Merrion Pharmaceuticals Plc., Ablynx, Genta Incorporated, Galapagos NV, Catena Pharmaceuticals Inc., Digna Biotech S.L., Medivir AB, Amura Holdings
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Candidiasis Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Candidiasis Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Candidiasis Therapeutics Market growing?

Ans: The Candidiasis Therapeutics Market witnessing a CAGR of 3.2% during the forecast period 2025-2031.

What is the Candidiasis Therapeutics Market size in 2031?

Ans: The Candidiasis Therapeutics Market size in 2031 will be US$ 3979 million.

Who are the main players in the Candidiasis Therapeutics Market report?

Ans: The main players in the Candidiasis Therapeutics Market are Novartis AG, Amgen, F. Hoffmann-La Roche Ltd., Bayer-Algeta, Merrion Pharmaceuticals Plc., Ablynx, Genta Incorporated, Galapagos NV, Catena Pharmaceuticals Inc., Digna Biotech S.L., Medivir AB, Amura Holdings

What are the Application segmentation covered in the Candidiasis Therapeutics Market report?

Ans: The Applications covered in the Candidiasis Therapeutics Market report are Multispecialty Hospitals, Cancer Research Institutes, Others

What are the Type segmentation covered in the Candidiasis Therapeutics Market report?

Ans: The Types covered in the Candidiasis Therapeutics Market report are Doxorubicin, Cisplatin, 7Carboplatin, Etoposide, Ifosfamide, Cyclophosphamide, Methotrexate, Vincristine

Recommended Reports

Infectious Disease Drugs

Cancer Therapeutics

Fungal & Rare Diseases

1 Candidiasis Therapeutics Market Overview
1.1 Product Definition
1.2 Candidiasis Therapeutics by Type
1.2.1 Global Candidiasis Therapeutics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Doxorubicin
1.2.3 Cisplatin
1.2.4 7Carboplatin
1.2.5 Etoposide
1.2.6 Ifosfamide
1.2.7 Cyclophosphamide
1.2.8 Methotrexate
1.2.9 Vincristine
1.3 Candidiasis Therapeutics by Application
1.3.1 Global Candidiasis Therapeutics Market Value by Application (2024 VS 2031)
1.3.2 Multispecialty Hospitals
1.3.3 Cancer Research Institutes
1.3.4 Others
1.4 Global Candidiasis Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Candidiasis Therapeutics Revenue 2020-2031
1.4.2 Global Candidiasis Therapeutics Sales 2020-2031
1.4.3 Global Candidiasis Therapeutics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Candidiasis Therapeutics Market Competition by Manufacturers
2.1 Global Candidiasis Therapeutics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Candidiasis Therapeutics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Candidiasis Therapeutics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Candidiasis Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Candidiasis Therapeutics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Candidiasis Therapeutics, Product Type & Application
2.7 Global Key Manufacturers of Candidiasis Therapeutics, Date of Enter into This Industry
2.8 Global Candidiasis Therapeutics Market Competitive Situation and Trends
2.8.1 Global Candidiasis Therapeutics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Candidiasis Therapeutics Players Market Share by Revenue
2.8.3 Global Candidiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Candidiasis Therapeutics Market Scenario by Region
3.1 Global Candidiasis Therapeutics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Candidiasis Therapeutics Sales by Region: 2020-2031
3.2.1 Global Candidiasis Therapeutics Sales by Region: 2020-2025
3.2.2 Global Candidiasis Therapeutics Sales by Region: 2026-2031
3.3 Global Candidiasis Therapeutics Revenue by Region: 2020-2031
3.3.1 Global Candidiasis Therapeutics Revenue by Region: 2020-2025
3.3.2 Global Candidiasis Therapeutics Revenue by Region: 2026-2031
3.4 North America Candidiasis Therapeutics Market Facts & Figures by Country
3.4.1 North America Candidiasis Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Candidiasis Therapeutics Sales by Country (2020-2031)
3.4.3 North America Candidiasis Therapeutics Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Candidiasis Therapeutics Market Facts & Figures by Country
3.5.1 Europe Candidiasis Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Candidiasis Therapeutics Sales by Country (2020-2031)
3.5.3 Europe Candidiasis Therapeutics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Candidiasis Therapeutics Market Facts & Figures by Region
3.6.1 Asia Pacific Candidiasis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Candidiasis Therapeutics Sales by Region (2020-2031)
3.6.3 Asia Pacific Candidiasis Therapeutics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Candidiasis Therapeutics Market Facts & Figures by Country
3.7.1 Latin America Candidiasis Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Candidiasis Therapeutics Sales by Country (2020-2031)
3.7.3 Latin America Candidiasis Therapeutics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Candidiasis Therapeutics Market Facts & Figures by Country
3.8.1 Middle East and Africa Candidiasis Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Candidiasis Therapeutics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Candidiasis Therapeutics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Candidiasis Therapeutics Sales by Type (2020-2031)
4.1.1 Global Candidiasis Therapeutics Sales by Type (2020-2025)
4.1.2 Global Candidiasis Therapeutics Sales by Type (2026-2031)
4.1.3 Global Candidiasis Therapeutics Sales Market Share by Type (2020-2031)
4.2 Global Candidiasis Therapeutics Revenue by Type (2020-2031)
4.2.1 Global Candidiasis Therapeutics Revenue by Type (2020-2025)
4.2.2 Global Candidiasis Therapeutics Revenue by Type (2026-2031)
4.2.3 Global Candidiasis Therapeutics Revenue Market Share by Type (2020-2031)
4.3 Global Candidiasis Therapeutics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Candidiasis Therapeutics Sales by Application (2020-2031)
5.1.1 Global Candidiasis Therapeutics Sales by Application (2020-2025)
5.1.2 Global Candidiasis Therapeutics Sales by Application (2026-2031)
5.1.3 Global Candidiasis Therapeutics Sales Market Share by Application (2020-2031)
5.2 Global Candidiasis Therapeutics Revenue by Application (2020-2031)
5.2.1 Global Candidiasis Therapeutics Revenue by Application (2020-2025)
5.2.2 Global Candidiasis Therapeutics Revenue by Application (2026-2031)
5.2.3 Global Candidiasis Therapeutics Revenue Market Share by Application (2020-2031)
5.3 Global Candidiasis Therapeutics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Company Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Candidiasis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis AG Candidiasis Therapeutics Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Candidiasis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Candidiasis Therapeutics Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 F. Hoffmann-La Roche Ltd.
6.3.1 F. Hoffmann-La Roche Ltd. Company Information
6.3.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.3.3 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Portfolio
6.3.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.4 Bayer-Algeta
6.4.1 Bayer-Algeta Company Information
6.4.2 Bayer-Algeta Description and Business Overview
6.4.3 Bayer-Algeta Candidiasis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer-Algeta Candidiasis Therapeutics Product Portfolio
6.4.5 Bayer-Algeta Recent Developments/Updates
6.5 Merrion Pharmaceuticals Plc.
6.5.1 Merrion Pharmaceuticals Plc. Company Information
6.5.2 Merrion Pharmaceuticals Plc. Description and Business Overview
6.5.3 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Portfolio
6.5.5 Merrion Pharmaceuticals Plc. Recent Developments/Updates
6.6 Ablynx
6.6.1 Ablynx Company Information
6.6.2 Ablynx Description and Business Overview
6.6.3 Ablynx Candidiasis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ablynx Candidiasis Therapeutics Product Portfolio
6.6.5 Ablynx Recent Developments/Updates
6.7 Genta Incorporated
6.7.1 Genta Incorporated Company Information
6.7.2 Genta Incorporated Description and Business Overview
6.7.3 Genta Incorporated Candidiasis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Genta Incorporated Candidiasis Therapeutics Product Portfolio
6.7.5 Genta Incorporated Recent Developments/Updates
6.8 Galapagos NV
6.8.1 Galapagos NV Company Information
6.8.2 Galapagos NV Description and Business Overview
6.8.3 Galapagos NV Candidiasis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Galapagos NV Candidiasis Therapeutics Product Portfolio
6.8.5 Galapagos NV Recent Developments/Updates
6.9 Catena Pharmaceuticals Inc.
6.9.1 Catena Pharmaceuticals Inc. Company Information
6.9.2 Catena Pharmaceuticals Inc. Description and Business Overview
6.9.3 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Portfolio
6.9.5 Catena Pharmaceuticals Inc. Recent Developments/Updates
6.10 Digna Biotech S.L.
6.10.1 Digna Biotech S.L. Company Information
6.10.2 Digna Biotech S.L. Description and Business Overview
6.10.3 Digna Biotech S.L. Candidiasis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Digna Biotech S.L. Candidiasis Therapeutics Product Portfolio
6.10.5 Digna Biotech S.L. Recent Developments/Updates
6.11 Medivir AB
6.11.1 Medivir AB Company Information
6.11.2 Medivir AB Description and Business Overview
6.11.3 Medivir AB Candidiasis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Medivir AB Candidiasis Therapeutics Product Portfolio
6.11.5 Medivir AB Recent Developments/Updates
6.12 Amura Holdings
6.12.1 Amura Holdings Company Information
6.12.2 Amura Holdings Description and Business Overview
6.12.3 Amura Holdings Candidiasis Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Amura Holdings Candidiasis Therapeutics Product Portfolio
6.12.5 Amura Holdings Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Candidiasis Therapeutics Industry Chain Analysis
7.2 Candidiasis Therapeutics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Candidiasis Therapeutics Production Mode & Process Analysis
7.4 Candidiasis Therapeutics Sales and Marketing
7.4.1 Candidiasis Therapeutics Sales Channels
7.4.2 Candidiasis Therapeutics Distributors
7.5 Candidiasis Therapeutics Customer Analysis
8 Candidiasis Therapeutics Market Dynamics
8.1 Candidiasis Therapeutics Industry Trends
8.2 Candidiasis Therapeutics Market Drivers
8.3 Candidiasis Therapeutics Market Challenges
8.4 Candidiasis Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
F Hoffmann La Roche Ltd
Bayer-Algeta
Merrion Pharmaceuticals Plc.
Genta Incorporated
Galapagos
Digna Biotech, S.L.
Amura Holdings
Amgen Inc
Ablynx NV
Catena Pharmaceuticals Inc.
List of Tables
 Table 1. Global Candidiasis Therapeutics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Candidiasis Therapeutics Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Candidiasis Therapeutics Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Candidiasis Therapeutics Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Candidiasis Therapeutics Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Candidiasis Therapeutics Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Candidiasis Therapeutics Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Candidiasis Therapeutics Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Candidiasis Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Candidiasis Therapeutics, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Candidiasis Therapeutics, Product Type & Application
 Table 12. Global Key Manufacturers of Candidiasis Therapeutics, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Candidiasis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candidiasis Therapeutics as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Candidiasis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Candidiasis Therapeutics Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Candidiasis Therapeutics Sales Market Share by Region (2020-2025)
 Table 19. Global Candidiasis Therapeutics Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Candidiasis Therapeutics Sales Market Share by Region (2026-2031)
 Table 21. Global Candidiasis Therapeutics Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Candidiasis Therapeutics Revenue Market Share by Region (2020-2025)
 Table 23. Global Candidiasis Therapeutics Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Candidiasis Therapeutics Revenue Market Share by Region (2026-2031)
 Table 25. North America Candidiasis Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Candidiasis Therapeutics Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Candidiasis Therapeutics Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Candidiasis Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Candidiasis Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Candidiasis Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Candidiasis Therapeutics Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Candidiasis Therapeutics Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Candidiasis Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Candidiasis Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Candidiasis Therapeutics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Candidiasis Therapeutics Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Candidiasis Therapeutics Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Candidiasis Therapeutics Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Candidiasis Therapeutics Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Candidiasis Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Candidiasis Therapeutics Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Candidiasis Therapeutics Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Candidiasis Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Candidiasis Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Candidiasis Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Candidiasis Therapeutics Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Candidiasis Therapeutics Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Candidiasis Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Candidiasis Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Candidiasis Therapeutics Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Candidiasis Therapeutics Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Candidiasis Therapeutics Sales Market Share by Type (2020-2025)
 Table 53. Global Candidiasis Therapeutics Sales Market Share by Type (2026-2031)
 Table 54. Global Candidiasis Therapeutics Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Candidiasis Therapeutics Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Candidiasis Therapeutics Revenue Market Share by Type (2020-2025)
 Table 57. Global Candidiasis Therapeutics Revenue Market Share by Type (2026-2031)
 Table 58. Global Candidiasis Therapeutics Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Candidiasis Therapeutics Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Candidiasis Therapeutics Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Candidiasis Therapeutics Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Candidiasis Therapeutics Sales Market Share by Application (2020-2025)
 Table 63. Global Candidiasis Therapeutics Sales Market Share by Application (2026-2031)
 Table 64. Global Candidiasis Therapeutics Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Candidiasis Therapeutics Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Candidiasis Therapeutics Revenue Market Share by Application (2020-2025)
 Table 67. Global Candidiasis Therapeutics Revenue Market Share by Application (2026-2031)
 Table 68. Global Candidiasis Therapeutics Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Candidiasis Therapeutics Price (USD/Pcs) by Application (2026-2031)
 Table 70. Novartis AG Company Information
 Table 71. Novartis AG Description and Business Overview
 Table 72. Novartis AG Candidiasis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Novartis AG Candidiasis Therapeutics Product
 Table 74. Novartis AG Recent Developments/Updates
 Table 75. Amgen Company Information
 Table 76. Amgen Description and Business Overview
 Table 77. Amgen Candidiasis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Amgen Candidiasis Therapeutics Product
 Table 79. Amgen Recent Developments/Updates
 Table 80. F. Hoffmann-La Roche Ltd. Company Information
 Table 81. F. Hoffmann-La Roche Ltd. Description and Business Overview
 Table 82. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product
 Table 84. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
 Table 85. Bayer-Algeta Company Information
 Table 86. Bayer-Algeta Description and Business Overview
 Table 87. Bayer-Algeta Candidiasis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Bayer-Algeta Candidiasis Therapeutics Product
 Table 89. Bayer-Algeta Recent Developments/Updates
 Table 90. Merrion Pharmaceuticals Plc. Company Information
 Table 91. Merrion Pharmaceuticals Plc. Description and Business Overview
 Table 92. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product
 Table 94. Merrion Pharmaceuticals Plc. Recent Developments/Updates
 Table 95. Ablynx Company Information
 Table 96. Ablynx Description and Business Overview
 Table 97. Ablynx Candidiasis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Ablynx Candidiasis Therapeutics Product
 Table 99. Ablynx Recent Developments/Updates
 Table 100. Genta Incorporated Company Information
 Table 101. Genta Incorporated Description and Business Overview
 Table 102. Genta Incorporated Candidiasis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Genta Incorporated Candidiasis Therapeutics Product
 Table 104. Genta Incorporated Recent Developments/Updates
 Table 105. Galapagos NV Company Information
 Table 106. Galapagos NV Description and Business Overview
 Table 107. Galapagos NV Candidiasis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Galapagos NV Candidiasis Therapeutics Product
 Table 109. Galapagos NV Recent Developments/Updates
 Table 110. Catena Pharmaceuticals Inc. Company Information
 Table 111. Catena Pharmaceuticals Inc. Description and Business Overview
 Table 112. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product
 Table 114. Catena Pharmaceuticals Inc. Recent Developments/Updates
 Table 115. Digna Biotech S.L. Company Information
 Table 116. Digna Biotech S.L. Description and Business Overview
 Table 117. Digna Biotech S.L. Candidiasis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Digna Biotech S.L. Candidiasis Therapeutics Product
 Table 119. Digna Biotech S.L. Recent Developments/Updates
 Table 120. Medivir AB Company Information
 Table 121. Medivir AB Description and Business Overview
 Table 122. Medivir AB Candidiasis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Medivir AB Candidiasis Therapeutics Product
 Table 124. Medivir AB Recent Developments/Updates
 Table 125. Amura Holdings Company Information
 Table 126. Amura Holdings Description and Business Overview
 Table 127. Amura Holdings Candidiasis Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Amura Holdings Candidiasis Therapeutics Product
 Table 129. Amura Holdings Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Candidiasis Therapeutics Distributors List
 Table 133. Candidiasis Therapeutics Customers List
 Table 134. Candidiasis Therapeutics Market Trends
 Table 135. Candidiasis Therapeutics Market Drivers
 Table 136. Candidiasis Therapeutics Market Challenges
 Table 137. Candidiasis Therapeutics Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Candidiasis Therapeutics
 Figure 2. Global Candidiasis Therapeutics Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Candidiasis Therapeutics Market Share by Type: 2024 & 2031
 Figure 4. Doxorubicin Product Picture
 Figure 5. Cisplatin Product Picture
 Figure 6. 7Carboplatin Product Picture
 Figure 7. Etoposide Product Picture
 Figure 8. Ifosfamide Product Picture
 Figure 9. Cyclophosphamide Product Picture
 Figure 10. Methotrexate Product Picture
 Figure 11. Vincristine Product Picture
 Figure 12. Global Candidiasis Therapeutics Market Value by Application (2020-2031) & (US$ Million)
 Figure 13. Global Candidiasis Therapeutics Market Share by Application: 2024 & 2031
 Figure 14. Multispecialty Hospitals
 Figure 15. Cancer Research Institutes
 Figure 16. Others
 Figure 17. Global Candidiasis Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Candidiasis Therapeutics Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Candidiasis Therapeutics Sales (2020-2031) & (K Pcs)
 Figure 20. Global Candidiasis Therapeutics Average Price (USD/Pcs) & (2020-2031)
 Figure 21. Candidiasis Therapeutics Report Years Considered
 Figure 22. Candidiasis Therapeutics Sales Share by Manufacturers in 2024
 Figure 23. Global Candidiasis Therapeutics Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Candidiasis Therapeutics Players: Market Share by Revenue in Candidiasis Therapeutics in 2024
 Figure 25. Candidiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Candidiasis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Candidiasis Therapeutics Sales Market Share by Country (2020-2031)
 Figure 28. North America Candidiasis Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Candidiasis Therapeutics Sales Market Share by Country (2020-2031)
 Figure 32. Europe Candidiasis Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Candidiasis Therapeutics Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Candidiasis Therapeutics Revenue Market Share by Region (2020-2031)
 Figure 40. China Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Taiwan Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Philippines Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Candidiasis Therapeutics Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Candidiasis Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Candidiasis Therapeutics Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Candidiasis Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. UAE Candidiasis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Candidiasis Therapeutics by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Candidiasis Therapeutics by Type (2020-2031)
 Figure 62. Global Candidiasis Therapeutics Price (USD/Pcs) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Candidiasis Therapeutics by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Candidiasis Therapeutics by Application (2020-2031)
 Figure 65. Global Candidiasis Therapeutics Price (USD/Pcs) by Application (2020-2031)
 Figure 66. Candidiasis Therapeutics Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Invasive Fungal Infection Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Aspergillosis Drugs Market Research Report 2024
Global Anti Infectives Market Research Report 2025
Global Gynecological Cancers Drug Market Research Report 2025
Global Oral Antifungal Drugs Market Insights Forecast to 2030
Global Still s Disease Treatment Market Research Report 2025
Global Oral Antifungals Market Insights Forecast to 2030
Global Oral Antifungal Medication Market Insights Forecast to 2030
Global Vaginitis Therapeutics Market Insights Forecast to 2030
Global Onychomycosis Therapy Market Research Report 2024
Global Topical Antifungals Market Research Report 2024
Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Amphotericin B API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Combination Therapy Drug Market Research Report 2025
Global Treatment Planning Software Market Research Report 2025
Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024
Global Diagnostic Guidewire Market Research Report 2024
Global Onychomycosis Treatment Technique Market Research Report 2024
Global Critical Care Therapeutics Market Research Report 2025
Global Ant Killer Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions